wfnn.info Started Coverage on CombiMatrix Helping Save Lives from Health Risks
Summary: http://freestock1.com and http://wfnn.info coverage on CombiMatrix helping save the world from health risks.
Seattle, WA (PRWEB) June 18, 2007 -- WFNN continues report on companies to highlight companies believed to have high growth prospects. Dr. Joseph Louis deBeauchamp posted his report on six sites to allow investors to read about these companies.
WFNN said, "In conclusion, their development programs fit together strategically and synergistically. Overall, CombiMatrix demonstrates the value of ever increasing shareholder value by building the best products possible from their technology. At the strategic level, build a presence in the most lucrative, synergistic areas. Does it all in a framework of maximum mutual benefit, where advances in one area give low-cost or zero-cost advances in others. With the government paying attention to the worldwide risks of plague and other bio-agents, the future for CombiMatrix appears never brighter. WFNN agrees with their business model: to focus on worldwide healthcare situations, risks of high cost and high potential volume of death. With their solutions of diagnostics, CombiMatrix provides a critical need for helping populations remain safe in this rapidly changing world. Even if you take a jet ride across the country, you might pick up a 'bug" that could compromise your life. WFNN sees the future price of the company stock going up three fold in the next year and approaching two dollars per share, from the current near seventy cents."
For information of these events examine: http://freestock1.com and http://wfnn.info for the information.
About CombiMatrix: CombiMatrix continues operations in headquartered near Seattle. CombiMatrix's patented electrochemical manufacturing process utilizes standard semiconductor technology, proprietary software, and chemistry to build arrays of materials -- molecule by molecule. The company's CustomArray™ products work as DNA microarrays. These microarrays show use in pharmaceutical, biotech, and agrochemical industries as well as in research and government markets. The company also uses its technology in synergistic internal programs for diagnostics development, drug development, and biodefense in addition to partnerships for nanomaterials development. When the country needs to know what threats happen, and how to treat them; CombiMatrix identifies the biological risks that occur, such as Tuberculosis.
Dr. Amit Kumar
CombiMatrix Corporation
6500 Harbour Heights Pkwy., Ste. 303
Mukilteo, WA 98275 (Map)
Phone: 425-493-2000
http://www.combimatrix.com
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1TcXVhLVByb2YtU2luZy1UaGlyLVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.